The Company develops and manufactures a new generation of medical robotics designed for accurate positioning, manipulation and stable control of catheters and catheter-based technologies.
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
> The Sensei is a dangerous piece of equipment for patients, leading to 17-19% complication rates.
> Dr. Fred Moll has lost all credibility after promising "slam dunk" guidance of 53-60 systems in 2009, after only delivering 3 in Q2 (conveniently after they pushed a secondary in April, have you.)
> Hansen's gross margins have eroded to close to 0% as ASPs have collapsed due to the lack of a value proposition.
> Hansen needs to completely restructure and reengineer its product for use in electrophysiology to be adopted clinically. A 17F sheath is too big for the vasculature, in particular, the femoral artery.
> Hansen has suffered the loss of talent, with spontaneous resignations from the President and COO, Gary Restani, to members of the board and key engineering talent.